Document is current
Any future updates will be listed below
-
Authors
Ciani, Oriana https://orcid.org/0000-0002-3607-0508
Federici, Carlo
Generali, Daniele
Zambelli, Alberto
-
Funding
Funding for this research was provided by:
Università Commerciale Luigi Bocconi
- License Information
-
More Information
Article History
Received: 9 April 2025
Accepted: 8 April 2026
First Online: 20 May 2026
Declarations
:
: This study did not require ethical approval from the Ethical Review Committee at Bocconi University. This article is based on previously collected aggregate or anonymised data.
: D.G. has received honoraria from Novartis, Lilly, AstraZeneca, Roche, Pfizer, and Menarini; research funding from Novartis; and travel/accommodation support from Novartis, Roche, and Pfizer. A.Z. has received honoraria and/or consulting fees from Eli Lilly, Novartis, and Roche/Genentech. He has also received travel, accommodations, and/or meeting support from the same companies. O.C. and C.F. declare no conflict of interest.
